Efficacy News and Research

RSS
Clinical data of cabozantinib to be presented at ASCO meeting

Clinical data of cabozantinib to be presented at ASCO meeting

Isis begins clinical study of ISIS-STAT3 in patients with metastatic liver cancer

Isis begins clinical study of ISIS-STAT3 in patients with metastatic liver cancer

Aileron Therapeutics concludes first-in-human study of ALRN-5281 Stapled Peptide drug

Aileron Therapeutics concludes first-in-human study of ALRN-5281 Stapled Peptide drug

AUA and ASTRO release new guideline on adjuvant and salvage radiotherapy after prostatectomy

AUA and ASTRO release new guideline on adjuvant and salvage radiotherapy after prostatectomy

New form of electroconvulsive therapy could prevent adverse cognitive side effects

New form of electroconvulsive therapy could prevent adverse cognitive side effects

Pharmapendium adds new module to benefit researchers and toxicologists

Pharmapendium adds new module to benefit researchers and toxicologists

Oral drops provide a safe and effective alternative for allergy sufferers

Oral drops provide a safe and effective alternative for allergy sufferers

Researchers issue statement regarding use of unproven stem cell therapies

Researchers issue statement regarding use of unproven stem cell therapies

Martindale Pharma announces UK launch of Prenoxad Injection for opioid overdose

Martindale Pharma announces UK launch of Prenoxad Injection for opioid overdose

Study brings opportunities of personalised therapy for breast cancer a step closer

Study brings opportunities of personalised therapy for breast cancer a step closer

Aclidinium and formoterol combination demonstrates significant lung function improvement in the second pivotal efficacy trial

Aclidinium and formoterol combination demonstrates significant lung function improvement in the second pivotal efficacy trial

Forest Laboratories, Almirall report positive topline results from AUGMENT COPD

Forest Laboratories, Almirall report positive topline results from AUGMENT COPD

NeuroSigma receives Class 2 medical device license for Monarch eTNS System from Health Canada

NeuroSigma receives Class 2 medical device license for Monarch eTNS System from Health Canada

Study shows efficacy of PEGylated liposomal doxorubicin in intracranial model of breast cancer

Study shows efficacy of PEGylated liposomal doxorubicin in intracranial model of breast cancer

New hope for patients with myotonic dystrophy

New hope for patients with myotonic dystrophy

Scientists pursue new therapies as H7N9 flu spreads in China

Scientists pursue new therapies as H7N9 flu spreads in China

New guidance on radioiodine therapy use after radiographic studies

New guidance on radioiodine therapy use after radiographic studies

Sufferers of gout and elevated uric acid levels have significantly increased death risks

Sufferers of gout and elevated uric acid levels have significantly increased death risks

FDA approves Octapharma USA's BLA for octaplex

FDA approves Octapharma USA's BLA for octaplex

IL-1 antagonist relieves dry eyes

IL-1 antagonist relieves dry eyes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.